Review



mass spectrometry data processing program peaks  (Bioinformatics Solutions Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Bioinformatics Solutions Inc mass spectrometry data processing program peaks
    (A) Comparison of identification performance between five mass <t>spectrometry</t> data processing tools based on number of identified peptides, proteins, and proteins identified with more than one peptide. (B) The number of identified and mapped proteins across the different programs. (C) Overlap of protein identification between different programs.
    Mass Spectrometry Data Processing Program Peaks, supplied by Bioinformatics Solutions Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mass+spectrometry+data+processing+program+peaks/pmc04780771-128-3-27?v=Bioinformatics+Solutions+Inc
    Average 90 stars, based on 1 article reviews
    mass spectrometry data processing program peaks - by Bioz Stars, 2026-07
    90/100 stars

    Images

    1) Product Images from "Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease"

    Article Title: Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0150672

    (A) Comparison of identification performance between five mass spectrometry data processing tools based on number of identified peptides, proteins, and proteins identified with more than one peptide. (B) The number of identified and mapped proteins across the different programs. (C) Overlap of protein identification between different programs.
    Figure Legend Snippet: (A) Comparison of identification performance between five mass spectrometry data processing tools based on number of identified peptides, proteins, and proteins identified with more than one peptide. (B) The number of identified and mapped proteins across the different programs. (C) Overlap of protein identification between different programs.

    Techniques Used: Comparison, Mass Spectrometry

    Comparison of the number of significantly altered proteins identified by different normalization methods and five mass spectrometry data processing tools.
    Figure Legend Snippet: Comparison of the number of significantly altered proteins identified by different normalization methods and five mass spectrometry data processing tools.

    Techniques Used: Comparison, Mass Spectrometry

    (A) Scatter plot of protein fold changes between mass spectrometry (reference normalization) and antibody-based analysis. The protein p-values and fold changes were calucluated using statistically significantly differentially altered peptides. (B) Scatter plot of protein fold changes between mass spectrometry (spiked-in normalization) and antibody-based profiling. After normalization with spiked-in method, the protein p-values and fold changes were computed using the same peptides as used in the panel A (C) Scatter plot of protein fold changes between mass spectrometry (spiked-in normalization) and a where the protein p-values and fold changes were computed using statistically significantly differentially altered peptides (proteins are shown based on Uniprot ID). MS: Mass spectrometry; ABA: antibody-based analysis.
    Figure Legend Snippet: (A) Scatter plot of protein fold changes between mass spectrometry (reference normalization) and antibody-based analysis. The protein p-values and fold changes were calucluated using statistically significantly differentially altered peptides. (B) Scatter plot of protein fold changes between mass spectrometry (spiked-in normalization) and antibody-based profiling. After normalization with spiked-in method, the protein p-values and fold changes were computed using the same peptides as used in the panel A (C) Scatter plot of protein fold changes between mass spectrometry (spiked-in normalization) and a where the protein p-values and fold changes were computed using statistically significantly differentially altered peptides (proteins are shown based on Uniprot ID). MS: Mass spectrometry; ABA: antibody-based analysis.

    Techniques Used: Mass Spectrometry

    Proteins selected from spiked-in normalized data that were verified in the antibody-based analysis as novel disease-associated markers for Alzheimer’s disease.
    Figure Legend Snippet: Proteins selected from spiked-in normalized data that were verified in the antibody-based analysis as novel disease-associated markers for Alzheimer’s disease.

    Techniques Used: Mass Spectrometry



    Similar Products

    mass spectrometry data processing program peaks  (Bioinformatics Solutions Inc)
    90
    Bioinformatics Solutions Inc mass spectrometry data processing program peaks
    (A) Comparison of identification performance between five mass <t>spectrometry</t> data processing tools based on number of identified peptides, proteins, and proteins identified with more than one peptide. (B) The number of identified and mapped proteins across the different programs. (C) Overlap of protein identification between different programs.
    Mass Spectrometry Data Processing Program Peaks, supplied by Bioinformatics Solutions Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mass+spectrometry+data+processing+program+peaks/pmc04780771-128-3-27?v=Bioinformatics+Solutions+Inc
    Average 90 stars, based on 1 article reviews
    mass spectrometry data processing program peaks - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Comparison of identification performance between five mass spectrometry data processing tools based on number of identified peptides, proteins, and proteins identified with more than one peptide. (B) The number of identified and mapped proteins across the different programs. (C) Overlap of protein identification between different programs.

    Journal: PLoS ONE

    Article Title: Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease

    doi: 10.1371/journal.pone.0150672

    Figure Lengend Snippet: (A) Comparison of identification performance between five mass spectrometry data processing tools based on number of identified peptides, proteins, and proteins identified with more than one peptide. (B) The number of identified and mapped proteins across the different programs. (C) Overlap of protein identification between different programs.

    Article Snippet: The following five mass spectrometry data processing programs were used to perform identification and quantification: Sieve v 2.1 (Thermo), DecyderMS v2.0 (GE healthcare), Maxquant [ ], PEAKS (Bioinformatics Solutions Inc.) and OpenMS [ ].

    Techniques: Comparison, Mass Spectrometry

    Comparison of the number of significantly altered proteins identified by different normalization methods and five mass spectrometry data processing tools.

    Journal: PLoS ONE

    Article Title: Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease

    doi: 10.1371/journal.pone.0150672

    Figure Lengend Snippet: Comparison of the number of significantly altered proteins identified by different normalization methods and five mass spectrometry data processing tools.

    Article Snippet: The following five mass spectrometry data processing programs were used to perform identification and quantification: Sieve v 2.1 (Thermo), DecyderMS v2.0 (GE healthcare), Maxquant [ ], PEAKS (Bioinformatics Solutions Inc.) and OpenMS [ ].

    Techniques: Comparison, Mass Spectrometry

    (A) Scatter plot of protein fold changes between mass spectrometry (reference normalization) and antibody-based analysis. The protein p-values and fold changes were calucluated using statistically significantly differentially altered peptides. (B) Scatter plot of protein fold changes between mass spectrometry (spiked-in normalization) and antibody-based profiling. After normalization with spiked-in method, the protein p-values and fold changes were computed using the same peptides as used in the panel A (C) Scatter plot of protein fold changes between mass spectrometry (spiked-in normalization) and a where the protein p-values and fold changes were computed using statistically significantly differentially altered peptides (proteins are shown based on Uniprot ID). MS: Mass spectrometry; ABA: antibody-based analysis.

    Journal: PLoS ONE

    Article Title: Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease

    doi: 10.1371/journal.pone.0150672

    Figure Lengend Snippet: (A) Scatter plot of protein fold changes between mass spectrometry (reference normalization) and antibody-based analysis. The protein p-values and fold changes were calucluated using statistically significantly differentially altered peptides. (B) Scatter plot of protein fold changes between mass spectrometry (spiked-in normalization) and antibody-based profiling. After normalization with spiked-in method, the protein p-values and fold changes were computed using the same peptides as used in the panel A (C) Scatter plot of protein fold changes between mass spectrometry (spiked-in normalization) and a where the protein p-values and fold changes were computed using statistically significantly differentially altered peptides (proteins are shown based on Uniprot ID). MS: Mass spectrometry; ABA: antibody-based analysis.

    Article Snippet: The following five mass spectrometry data processing programs were used to perform identification and quantification: Sieve v 2.1 (Thermo), DecyderMS v2.0 (GE healthcare), Maxquant [ ], PEAKS (Bioinformatics Solutions Inc.) and OpenMS [ ].

    Techniques: Mass Spectrometry

    Proteins selected from spiked-in normalized data that were verified in the antibody-based analysis as novel disease-associated markers for Alzheimer’s disease.

    Journal: PLoS ONE

    Article Title: Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease

    doi: 10.1371/journal.pone.0150672

    Figure Lengend Snippet: Proteins selected from spiked-in normalized data that were verified in the antibody-based analysis as novel disease-associated markers for Alzheimer’s disease.

    Article Snippet: The following five mass spectrometry data processing programs were used to perform identification and quantification: Sieve v 2.1 (Thermo), DecyderMS v2.0 (GE healthcare), Maxquant [ ], PEAKS (Bioinformatics Solutions Inc.) and OpenMS [ ].

    Techniques: Mass Spectrometry